US FDA approves Eyenovia's eye drug, Formosa Pharma says
March 4 (Reuters) - The U.S. Food and Drug
Administration approved Eyenovia's EYEN.O eye drops to reduce
inflammation and pain in patients who have undergone eye
surgery, Formosa Pharmaceuticals 6838.TWO said on Monday.
Eyenovia acquired U.S. commercial rights of the drug in
August last year from Formosa Pharmaceuticals.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shounak
Dasgupta)
((Sriparna.Roy@thomsonreuters.com))
Recent news on Hyperion DeFi
See all newsHyperion DeFi Inc reports results for the quarter ended September 30 - Earnings Summary
Hyperion DeFi posts third straight record quarterly profit
Hyperion DeFi Inc expected to post earnings of $1.81 a share - Earnings Preview
Brief: Hyperion Defi Raises Guidance And Announces $20M Share Repurchase Program
Hyperion DeFi Inc reports results for the quarter ended June 30 - Earnings Summary